HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.2250
0.0000 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.2250
Open0.2300
Bid0.2250 x 0
Ask0.2300 x 0
Day's Range0.2250 - 0.2350
52 Week Range0.0750 - 0.9400
Volume3,136,562
Avg. Volume7,131,668
Market Cap312.25M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • FSD Pharma to Present at Arcview Investor Forum
    CNW Group3 days ago

    FSD Pharma to Present at Arcview Investor Forum

    TORONTO , April 17, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), announced today that Dr. Raza Bokhari , Co-Chairman and Chief Executive Officer of FSD Pharma will participate in the Arcview Investor Forum being held April 23-25, 2019 , in Vancouver . Dr. Sara May , the recently appointed president of FV Pharma, will participate in a panel about investing in plant genetics. FSD Pharma is focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome.

  • Newsfile7 days ago

    FSD Pharma, Experienced CEO Has Brought Good Returns for Investors, CEO Clip Video

    Vancouver, British Columbia--(Newsfile Corp. - April 12, 2019) - New CEO Raza Bokhari discusses exciting partnerships with Canntab and World Class Extraction. If you cannot view the video above, please visit:https://www.b-tv.com/fsd-ceo-clip-90-sec-v3/FSD Pharma is being featured on BNN Bloomberg on Apr. 13 - Apr. 14, 2019, throughout the day and evenings.FSD Pharma (CSE: HUGE)fsdpharma.comAbout CEO Clips:CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 90 ...

  • GlobeNewswire9 days ago

    FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada -- CFN Media

    SEATTLE, April 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing FSD Pharma Inc. (HUGE.CN) (FSDDF) (FFT:0K9). The company has recognized these trends and recently hired an insurance expert to plan out its approach ahead of its sales license that’s expected later this year. Cannabis investors have been focused largely on the recreational market with the legalization of adult-use cannabis last year, but a growing body of research suggests that medical cannabis remains a compelling long-term opportunity.

  • GlobeNewswire10 days ago

    Cannabis Sticks to its Roots: Cannabis Companies Continue to Prioritize the Importance of “People”

    Chemistree Technology Inc. (CSE:CHM) (OTCQB: CHMJF), an investment company dedicated to the US cannabis sector endeavoring to provide turn-key solutions for the regulated cannabis industry, recently announced the addition of Nicholas J. Zitelli, a.k.a. Mr. Zitelli is a well-known cannabis industry leader.

  • FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the Scientific Advisory Board
    CNW Group16 days ago

    FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the Scientific Advisory Board

    TORONTO , April 4, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), announced today the appointment of Charles V. Pollack, Jr. , M.A., M.D., FACEP, FAAEM, FAHA, FACC, FESC, FCPP, as Chairman of its Scientific Advisory Board ("SAB"). In this capacity Dr. Pollack will serve as a strategic guide and resource to the Company as it develops disruptive, science-based, cannabinoid therapeutics. "We are very happy to have Dr. Pollack join FSD Pharma as the Chairman of our SAB.

  • FSD Pharma to Establish Presence in Canada's Insurance Regimes
    CNW Group23 days ago

    FSD Pharma to Establish Presence in Canada's Insurance Regimes

    TORONTO , March 28, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), announced today the signing of a consulting agreement with Joseph L. Romano , a well-respected lawyer with a strong track-record in personal injury law. Mr. Romano has been working with medical cannabis since 2006, assisting people coping with chronic pain to have access to medical cannabis, a viable alternative to opioid based medications. Pursuant to the terms of the agreement, Mr. Romano will provide consulting on the inner workings of third party actions, WSIB claim handling, first party coverage and no fault benefits across Canada .

  • Business Wire23 days ago

     FSD Pharma to Establish Presence in Canada’s Insurance Regimes

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), announced today the signing of a consulting agreement with Joseph L. Romano, a well-respected lawyer with a strong track-record in personal injury law. Mr. Romano has been working with medical cannabis since 2006, assisting people coping with chronic pain to have access to medical cannabis, a viable alternative to opioid based medications. Pursuant to the terms of the agreement, Mr. Romano will provide consulting on the inner workings of third party actions, WSIB claim handling, first party coverage and no fault benefits across Canada.

  • GlobeNewswirelast month

    The SunnySide of Cannabis; Cannabis Growth Boosts Solar Market

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases the first article in a two part series on how the growing global cannabis market is boosting ancillary markets, including the solar/cleantech industry. “And that's not counting jobs indirectly related to the marijuana industry, like lawyers, accountants, security consultants, media companies, and marketing firms. One sector getting a major boost from cannabis is solar, due in part to the high energy requirements of indoor grow facilities and the cannabis industry as a whole.

  • FSD Pharma Announces New Leadership Appointment and Board Change
    CNW Grouplast month

    FSD Pharma Announces New Leadership Appointment and Board Change

    TORONTO , March 13, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), a licensed producer under the Cannabis Act, today announced that Sara May , Ph.D., has been appointed President of FV Pharma ("FV"), a wholly owned subsidiary of FSD Pharma, effective immediately. Dr. May replaces Thomas Fairfull , former President of FV Pharma, as Mr. Fairfull transitions out of the company.

  • GlobeNewswire2 months ago

    FSD Pharma's Investments Provide Unique Diversification -- CFN Media

    SEATTLE, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE:HUGE) (FSDDF) (0K9.F). The company is best known for its 3.8 million square foot former Kraft Foods facility in Cobourg, Ontario, which could make it one of the largest licensed producers in the country, if approved by Health Canada. In addition to this massive footprint, the company has established many strategic alliances that have gone under-the-radar for many investors, but could generate significant long-term value.

  • GlobeNewswire2 months ago

    Cannabis and Cleantech; The Green, Clean Machine of The Future

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing interest in renewable energy and sustainable practices within the cannabis industry, sparked largely by high demand, high energy usage and a need for companies to lower costs and improve efficiency. “Legal cannabis cultivation in the U.S. consumes an estimated 1.1 terawatt-hours of electricity a year,” according to the 2018 Cannabis Energy Report, published by Scale Microgrid Solutions, along with New Frontier Data and the Resource Innovation Institute. Aurora Cannabis Inc. (TSX:ACB.TO) (NYSE:ACB) has been aware of this need for energy efficiency since 2017, having partnered with Flora Fotonica through the company’s subsidiary MedReleaf.

  • GlobeNewswire2 months ago

    FSD Pharma's Investments in Cutting-Edge Tech Could Pay Big Dividends -- CFN Media

    SEATTLE, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE:HUGE) (FSDDF) (0K9.F). The company has become well-known for its massive cannabis cultivation facility that’s being built in a former Kraft plant in Cobourg, Ontario, but investors should also take note of its investment in cutting-edge research and development, including delivery systems and cultivation techniques. Many cannabis companies have predictable business models—they grow and sell cannabis flower or perhaps extract them into edibles or vape pens.

  • FSD Pharma Provides Update on Operations, Strategy and Leadership
    CNW Group2 months ago

    FSD Pharma Provides Update on Operations, Strategy and Leadership

    TORONTO , Feb. 14, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD"), a licensed producer under the Cannabis Act, today provided a corporate update on operations, strategy and leadership changes. On February 6, 2019 , the Company announced it had implemented changes in leadership and business practices to optimize operations. Accordingly, the Company announced that Dr. Raza Bokhari , Executive Co-Chairman, has been appointed interim Chief Executive Officer of FSD Pharma.

  • GlobeNewswire2 months ago

    CBD Med Research and World Class Extractions Announce Signing of Definitive Agreement

    CBD Med Research Corp. (“CBD”) and World Class Extractions Inc. (“World Class”) are pleased to announce, further to the parties’ press release dated August 15, 2018, the execution of a definitive business combination agreement (the “Combination Agreement”) on February 13, 2019 which, subject to certain conditions and applicable shareholder and regulatory approvals, will result in a reverse takeover of CBD by World Class (the “Proposed Transaction”). The resulting issuer that will exist upon completion of the Proposed Transaction (the “Resulting Issuer) intends to apply to the Canadian Securities Exchange (“CSE”) for approval for listing its common shares on the CSE. The technology allows the extraction of CBD Oil and other related extracts from wet or dried natural plants.

  • Business Wire2 months ago

    FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) (“FSD”), a licensed producer under the Cannabis Act, announced today that it has entered into a supply agreement (the “Agreement”) with Canntab Therapeutics Ltd. (“Canntab”) and World Class Extractions Inc. (“World Class”) (the “Purchasers”) to purchase hemp flower from Thomas Elcome (the “Supplier”). Pursuant to the agreement, the Purchasers have agreed to buy approximately 1,000 kg of the Supplier’s 2018 hemp crop at a purchase price of $100.00 per kg per 1% of CBD extracted from the flower.

  • Market Exclusive2 months ago

    FSD Pharma to Use Pharmastrip Equipment to Make Cannabis-Infused Oral Strips

    FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) made a $1.5-million investment in Pharmastrip Corp. and inked an agreement with the company as part of its plans to produce cannabis products. Under the terms of the agreement, FSD will install Pharmastrip equipment at its facility in Cobourg, Ontario. The company will use the equipment to manufacture organic […]The post FSD Pharma to Use Pharmastrip Equipment to Make Cannabis-Infused Oral Strips appeared first on Market Exclusive.

  • FSD Pharma responds to and corrects misleading Auxly claims
    CNW Group2 months ago

    FSD Pharma responds to and corrects misleading Auxly claims

    FSD Pharma strongly denies that it caused any breaches of the Streaming Agreement relating to its management and staffing obligations or otherwise, and rejects the claim that there are material issues with the infrastructure of its cultivation facility in Cobourg, Ontario . "FSD's Board and management team are focused on taking action to deliver on a strategy that promotes growth and creates shareholder value. As disclosed on Wednesday, February 6 , FSD terminated the Definitive Agreement with Auxly.

  • Business Wire2 months ago

    FSD Pharma Responds to and Corrects Misleading Auxly Claims

    FSD Pharma Inc.(HUGE.CN) (FSDDF) (0K9.F) a licensed producer under the Cannabis Act, responded today to a press release by its former partner, Auxly Cannabis Group Inc. (“Auxly”) to correct misleading claims. FSD Pharma strongly denies that it caused any breaches of the Streaming Agreement relating to its management and staffing obligations or otherwise, and rejects the claim that there are material issues with the infrastructure of its cultivation facility in Cobourg, Ontario. “FSD’s Board and management team are focused on taking action to deliver on a strategy that promotes growth and creates shareholder value.

  • GlobeNewswire2 months ago

    Auxly Announces Termination of FSD Pharma Joint Venture

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced the termination of the definitive agreement dated March 3, 2018 (the “Agreement”) between the Company and FV Pharma Inc., a wholly-owned subsidiary of FSD Pharma Inc. (“FSD Pharma”) (CSE:HUGE) governing the joint venture between the parties. The joint venture was formed with the intention of developing a portion of FSD Pharma's cannabis cultivation facility located in Cobourg, Ontario (the “JV Facility”) in mutually agreed staged phases (the “JV Facility Development”).

  • FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips
    CNW Group2 months ago

    FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips

    TORONTO , Feb. 7, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company), a licensed producer under the Cannabis Act, announced today that it has completed a strategic investment of $1.5 million in Pharmastrip Corp. and signed a definitive collaboration and profit sharing agreement with the company, effective January 23, 2019 . Under the terms of the agreement, FSD will install Pharmastrip proprietary equipment at its facility in Cobourg, Ontario .